G4P

G4P is a biotechnology company focused on the discovery and development of small molecule therapeutics that target G-quadruplex (G4) DNA and RNA structures. These non-canonical nucleic acid structures play critical roles in regulating gene expression and are frequently found in the promoters of oncogenes and the genomes of pathogens. By leveraging its proprietary platform, G4P aims to create highly selective ligands that can modulate these structures to treat cancer and other life-threatening diseases. The company's approach represents a novel frontier in precision medicine, targeting previously undruggable genomic regions.